Literature DB >> 8537591

Use of cardiovascular drugs in an older Swedish population.

P Wills1, J Fastbom, C B Claesson, C Cornelius, M Thorslund, B Winblad.   

Abstract

OBJECTIVE: To describe the use of cardiovascular drugs in an older population with respect to age, sex, housing type, and creatinine clearance.
DESIGN: A cross-sectional survey. PARTICIPANTS: All residents of a district of Stockholm (Kungsholmen), Sweden, aged 75 and older, living in institutions or at home. MEASUREMENTS: Cardiovascular drug use, serum creatinine, electrolytes, height, weight, and symptoms.
RESULTS: A total of 43 cardiovascular (CV) drugs were used. The most common drugs were digoxin (used by 18.2%), furosemide (16.4%), and glyceryl trinitrate (12.4%). Drugs with an antihypertensive effect accounted for 61% of all CV drugs. CV drug use increased with age for cardiac glycosides and diuretics, but decreased with age for calcium antagonists and beta-blockers. Drug doses tended to be less than the recommended daily dose except for a few drugs, e.g., furosemide. There was a trend toward decreasing dose with increasing age, but this was not significant. Diuretics were the only CV drugs used more often in women. People living in institutional care used the least amount of CV drugs. The dose of drugs taken did not appear to be related to estimated creatinine clearance. Comparisons between drug use and complaint of symptoms showed a strong correlation between the use of cardiac glycosides and anorexia, calcium antagonists and constipation, and nitrates and vertigo. There were weaker correlations with cardiac glycosides and visual disturbances and with potassium sparing diuretics and a high potassium.
CONCLUSIONS: CV drugs are used commonly in older people. We suggest that the symptoms correlating with cardiac glycoside use may be signs of unrecognized toxicity, and this may relate to our finding that drug use is often not tailored to renal function as measured by creatinine clearance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8537591     DOI: 10.1111/j.1532-5415.1996.tb05638.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  5 in total

Review 1.  Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction.

Authors:  D J van Kraaij; R W Jansen; F W Gribnau; W H Hoefnagels
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

2.  Prescription patterns of diuretics in Dutch community-dwelling elderly patients.

Authors:  D J van Kraaij; R W Jansen; J J de Gier; F W Gribnau; W H Hoefnagels
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

3.  Chronic constipation in hemiplegic patients.

Authors:  F Bracci; D Badiali; P Pezzotti; G Scivoletto; U Fuoco; L Di Lucente; A Petrelli; E Corazziari
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

4.  Digoxin and mortality in atrial fibrillation: a prospective cohort study.

Authors:  Pär Hallberg; Johan Lindbäck; Bertil Lindahl; Ulf Stenestrand; Håkan Melhus
Journal:  Eur J Clin Pharmacol       Date:  2007-08-08       Impact factor: 2.953

Review 5.  Benefits of optimising drug treatment in home-dwelling elderly patients with coronary artery disease.

Authors:  Timo Strandberg; Kaisu Pitkala; Reijo Tilvis
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.